Serum sulfatide level is associated with severe systemic vasculitis with kidney involvement

Area of Science:

• Biochemistry
• Immunology
• Nephrology

Background:

• Sulfatides, sulfated glycosphingolipids, are implicated in vascular inflammation, coagulation, and platelet aggregation.
• Systemic vasculitis (SV) encompasses autoimmune diseases often affecting kidneys, potentially causing rapid dysfunction and end-stage kidney disease.
• Previous research indicated reduced serum sulfatides (SSs) in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) with active kidney lesions.

Purpose of the Study:

• To investigate the clinical significance of serum sulfatides (SSs) in patients with systemic vasculitis and kidney involvement (SVKI).
• To compare SS levels across different types of SVKI diseases and control groups.
• To assess the association between SS levels and kidney biopsy findings in SVKI.

Main Methods:

• A retrospective cohort study analyzed SS levels in 26 IgA vasculitis (IgAV), 62 AAV, and 10 anti-glomerular basement membrane disease (GBM) patients (SVKI).
• Control groups included 50 IgA nephropathy (IgAN) patients and 23 living kidney transplant donors.
• SS levels were measured and compared across disease groups and correlated with kidney biopsy classifications.

Main Results:

• Mean SS levels were significantly lower in SVKI groups (IgAV: 6.01 ± 1.73, AAV: 5.37 ± 1.97, GBM: 2.73 ± 0.99 nmol/mL) compared to controls (Donor: 8.26 ± 1.72, IgAN: 8.01 ± 2.21 nmol/mL).
• Patients with crescentic class kidney biopsy findings within the SVKI group exhibited significantly lower SS levels than those with other biopsy classes.
• SS levels demonstrated high diagnostic ability for identifying SVKI patients with crescentic kidney biopsy findings (AUC 0.90).

Conclusions:

• Serum sulfatide levels are decreased in more severe forms of systemic vasculitis with kidney involvement (SVKI).
• Reduced SS levels are associated with active glomerular lesions, specifically crescent formation, in SVKI kidney biopsies.
• SS may serve as a potential biomarker for disease severity and activity in SVKI.